Pharma

The institute said on Friday it will get funding to support manufacturing for candidate vaccines from AstraZeneca and Novavax.

Zydus plans to complete late-stage trials for ZyCoV-D by February or March and could produce up to 100 million doses a year initially.

AstraZeneca has indicated it would need 30 million fill-and-finish doses of their vaccine candidate, which the company intends to supply in the next few months, Wockhardt's chairman said.

Aquinox Pharmaceuticals is a research and development company focused on pharmaceutical products for the purpose of their commercialisation, Sun Pharma said.

Cipla said it would launch favipiravir as "Ciplenza" in the first week of August, priced at Rs 68 (91 cents) per 200 mg tablet.

Glenmark denied making any claims that "favipiravir alone" is effective in treatment of mild-to-moderate COVID-19 patients.

The drug, which is also used to cure the skin disease psoriasis, was cleared by the Drug Controller General of India (DCGI) for usage in the country.

Sources said the first batch of 10,000 vials had been printed with a price of Rs 4,000, Rs 800 below the cheapest option, launched by European competitor Mylan this week.

Piramal Pharma Share Price: Piramal Enterprises shares rose to as high as Rs 1,387.55 apiece on the BSE during the session.

Piramal Pharma will use the capital raised through the dealto accelerate its organic and inorganic growth plans.

Hetero said its generic version of US-based Gilead Science's Remdesivir will be marketed under brand name Covifor in India.

The High Powered Committee said that Malvinder Mohan Singh was at liberty to file a bail application before courts concerned, which shall consider the same on merits in accordance with the law.

Favipiravir is made under the brand name Avigan by Japan's Fujifilm Holdings Corp and was approved for use as an anti-flu drug there in 2014.

Remdesivir, intravenously administered in hospitals, has already been approved for emergency use in severely-ill patients in the United States, India and South Korea.

Antiviral drug remdesivir was the first treatment to show improvement in COVID-19 trials.